Lack of medical investment, healthcare infra big challenges for India's COVID-19 fight: Fitch
"The continued lack of medical funding and healthcare infrastructure inform our view for the potential epidemic to be worse in India if it is not adequately contained," Fitch Solutions Country Risk and Industry Research (a unit of Fitch Group) said in its outlook for India's pharmaceutical market.
With 8.5 hospital beds per 10,000 citizens and eight physicians per 10,000, the country's healthcare sector is not equipped for such a crisis.Moreover, the significant inefficiency, dysfunctioning and acute shortage of the healthcare delivery systems in the public sector do not match up with the growing needs of the population.
Furthermore, over the last two decades, the availability of free medicines in public healthcare facilities has declined from 31.2 per cent to 8.9 per cent for inpatient care, and from 17.8 per cent to 5.9 per cent for outpatient care, the rating agency said citing a Public Health Foundation of India study.It also said that the growth within India's pharmaceuticals and healthcare market will be supported by the government's push towards achieving universal health coverage status.
An improving business environment and planned healthcare reforms will be positive for innovative drugmakers and as such the market will continue to hold significant potential as the third-largest pharmaceutical market in the Asia-Pacific region, it said. SID SID ANSANS
(This story has not been edited by Business Insider and is auto-generated from a syndicated feed we subscribe to.)
- Xiaomi patents new foldable smartphone
- Top 10 richest people in Canada according to Forbes as of March 7, 2021
- Global market for desktops, notebooks and tablets to grow 8% in 2021, says new report
- Porsche unveils its first pair of electric bikes priced at $8,549
- Facebook removes 915 malicious accounts and 606 fake accounts from Instagram in February